Editorial: Measurable residual disease in hematologic malignancies
- PMID: 37234991
- PMCID: PMC10206393
- DOI: 10.3389/fonc.2023.1204393
Editorial: Measurable residual disease in hematologic malignancies
Keywords: MRD - measurable residual disease; chimerism after allo-HSCT; multiparameter flow cytometry; next generation flow cytometry (NGF); next generation sequencing; polymerase chain reaction; surrogate endpoint biomarker.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Comment on
- Editorial on the Research Topic Measurable residual disease in hematologic malignancies
Publication types
LinkOut - more resources
Full Text Sources